HLA-DQA1*05 ALLELE CARRAIGE AND ANTI-TNF THERAPY PERSISTENCE IN INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Doherty, Jayne
Ryan, Anthony W.
Quinn, Emma
Dolan, Jackie
Corcoran, Roisin
O'Hara, Fintan
Bailey, Yvonne
Mcnamara, Deirdre
Doherty, Glen
Kevans, David
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1796
引用
收藏
页码：S435 / S436
页数：2
相关论文
共 50 条
  • [31] A novel HLA-DQA1 allele, DQA1*01:05:03, identified in a patient with suspected celiac disease
    Mahmood, Faiza
    Saether, Per C.
    HLA, 2020, 96 (01) : 117 - 118
  • [32] Proactive Therapeutic drug monitoring of Infliximab, but not HLA-DQA1*05, predicts clinical outcome in inflammatory bowel disease
    Alonso, I.
    Carrillo Palau, M.
    Vera, B.
    Vela, M.
    Morant, A.
    Ramos, L.
    Reygosa, C.
    Medina Chico, J. S.
    Barrios, Y.
    Franco, A.
    Gutierrez-Nicolas, F.
    Jimenez, A.
    Hernandez-Guerra, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I597 - I597
  • [33] HISPANIC IBD PATIENTS WITH HLA-DQA1*05 HAVE HIGHER RATES OF ANTI-TNF IMMUNOGENICITY COMPARED TO NON-CARRIERS
    Ioannou, Stephanie
    Beecham, Ashley Harris
    Gomez, Lissette
    Dauer, Ryan M.
    Khakoo, Nidah S.
    Pascual, Lauren
    Quintero, Maria
    Mills, Grechen
    Lopez, Joanna
    Leavitt, James S.
    Solis, Norma I.
    Deshpande, Amar R.
    Kerman, David H.
    Abreu, Maria T.
    McCauley, Jacob L.
    Damas, Oriana M.
    GASTROENTEROLOGY, 2021, 160 (06) : S72 - S72
  • [34] The novel HLA-DQA1*05:05:17:03 allele, identified in a potential organ donor
    Al Agbar, Sabina
    Sharma, Arpit
    Cohoe, Elsa
    Beaune, David
    Sidahmed, Abubaker M. E.
    HLA, 2024, 103 (04)
  • [35] Characterization of the novel HLA-DQA1*05:05:14 allele by sequencing-based typing
    Cargou, Marine
    Andreani, Marco
    Battarra, Mariarosa
    Ralazamahaleo, Mamy
    Visentin, Jonathan
    HLA, 2023, 101 (03) : 299 - 300
  • [36] HLA DQA1*05 was not associated to primary non-response or loss of response to first anti-TNF in real world Inflammatory Bowel Disease patients.
    Oliver, A. Pascual
    Cuaran, C.
    Casas-Deza, D.
    Garcia-Lopez, S.
    Corsino-Roche, P.
    Sierra Moros, E.
    Julian-Gomara, A. B.
    Vicente-Lidon, R.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 756 - 757
  • [37] Association of the HLA-DQA1*05 Allelic Gene Variants with Immunogenicity to Anti-TNF therapeutics-Important Differences Between Infliximab and Adalimumab
    Ternette, Nicola
    Liao, Hanqing
    Satsangi, Jack
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [38] Anti-TNF Therapy in the Swiss Inflammatory Bowel Disease Cohort
    Hiroz, Philippe
    Fournier, Nicolas
    Safroneeva, Ekaterina
    Moradpour, Darius
    Schoepfer, Alain M.
    SWISS MEDICAL WEEKLY, 2012, 142 : 12S - 12S
  • [39] Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
    Levin, Alon D.
    Wildenberg, Manon E.
    van den Brink, Gijs R.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (08): : 989 - 997
  • [40] Inflammatory bowel disease and targeted oral anti-TNFα therapy
    Griffiths, Owen R.
    Landon, John
    Coxon, Ruth E.
    Morris, Keith
    James, Philip
    Adams, Rachel
    INFLAMMATORY DISORDERS, PT A, 2020, 119 : 157 - 198
12345